drugset / Trial / NCT00422331

Safety and Efficacy Study of Lithium in Bipolar Disorder

NCT00422331

Phase 3 Unknown 206 enrolled JDS Pharmaceuticals
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether Lithium is safe and effective in the treatment of Bipolar I Disorder subjects with symptoms of acute mania.

Timeline

Start
2007-01
Primary completion
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown